Solar Industries India Limited is entering a decisive growth phase as defence manufacturing transitions from development to commercial execution.
News in Focus


Dalmia Bharat Limited delivered a resilient Q3FY26 performance, driven by healthy volume growth, disciplined cost management, and improving operating leverage.

Exide Industries is entering a decisive phase in its multi-year transformation.

The crash-game space has been moving fast lately, and Tower Rush has stepped into the spotlight with surprising confidence.

Mahindra Lifespace Developers has reached a long-awaited inflection point.

BOB Capital Markets Ltd has reiterated its BUY call on Adani Ports and Special Economic Zone Ltd, setting a target price of Rs 1,960, implying an upside of nearly 28% from current levels.
Main Regional Stories

Power Grid Corporation of India, the country’s dominant power transmission utility, is entering a structurally stronger execution phase after several quarters of muted performance.

Bajaj Finance’s Q3FY26 performance reflects a deliberate trade-off between short-term profitability and long-term balance-sheet strength.

Axis Securities has maintained its BUY recommendation on Chalet Hotels Limited with a target price of Rs 1,120, implying a 25% upside from the current market price of Rs 896.

ICICI Securities has reiterated a BUY call on Hyundai Motor India (HMIL), citing resilient execution in Q3FY26 despite near-term margin pressures linked to capacity expansion.
High levels of several vitamin E components in the blood are associated with a decreased risk for Alzheimer's disease (AD) in advanced age, a Swedish study has revealed.
McDonald's would defend itself against charges that Happy Meals gifts tempt children into poor eating habits, the U. S. franchise giant's chief executive has said.
Bafna Pharmaceuticals, a BSE-listed company, declared that its has got nod from medicines and healthcare products regulatory agency of the UK (UK MHRA) for making a muscle relaxant drug 'Clonazepam' in the capacity of 0.5 mg and 2 mg.
Considering the word's surging popularity Prakash Jha has registered the title Karaara for one of his future projects.








